Inflammasomes are multi‐protein signaling scaffolds that assemble in response to invasive pathogens and sterile danger signals to activate inflammatory caspases, which trigger inflammatory death (pyroptosis) and processing and release of pro‐inflammatory cytokines. Inflammasome activation contributes to many human diseases, including sepsis, the often‐fatal response to systemic infection. We recently found that gasdermin D (GSDMD) causes pyroptosis by forming pores in the plasma membrane after it is cleaved by the inflammatory caspases. The N‐terminal fragment binds to acidic phospholipids on the inner leaflet. GSDMD pores also assemble on bacterial membranes to kill the bacteria that trigger pyroptosis. Cryo‐electron microscopy was used to solve the structure of the pore formed by 27 monomers of the related gasdermin, gasdermin A3. The N‐terminal fragment undergoes radical conformational changes after it binds to lipids to assemble into a 108‐stranded b‐barrel that inserts into the membrane to form the pore. A small molecule screen identified several compounds that inhibit pore formation by covalently binding to a reactive cysteine in GSDMD and also inhibit other steps in inflammasome priming and assembly and caspase activation. One of the inhibitors, disulfiram, which is a drug used to treat alcohol dependence, promoted survival and reduced inflammatory cytokine secretion in LPS‐induced sepsis in mice. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .